NCT04794010View on ClinicalTrials.gov

A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

825

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

December 22, 2027

Study Completion Date

December 22, 2027

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (1)

04277

Local Institution - 0001, Leipzig

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04794010 - A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter